S2e-Leitlinie der Deutschen Urologen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

S2e-Leitlinie der Deutschen Urologen

Published:2015-11-01 Issue:2 Volume:55 Page:184-194
ISSN:0340-2592
Container-title:Der Urologe
language:de
Short-container-title:Urologe

Author:

Höfner K.,Bach T.,Berges R.,Dreikorn K.,Gratzke C.,Madersbacher S.,Michel M.-S.,Muschter R.,Oelke M.,Reich O.,Tschuschke C.,Bschleipfer T.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00120-015-3984-z.pdf

Reference124 articles.

1. Abrams P, Andersson KE (2007) Muscarinic receptor antagonists for overactive bladder. BJU Int 100:987–1006

2. Abrams P, Kaplan S, De Koning Gans HJ et al (2006) Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 175:999–1004

3. Abrams P, Schafer W, Tammela TL et al (1999) Improvement of pressure flow parameters with finasteride is greater in men with large prostates. Finasteride Urodynamics Study Group. J Urol 161:1513–1517

4. Abrams P, Speakman M, Stott M et al (1997) A dose-ranging study of the efficacy and safety of tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist, in patients with benign prostatic obstruction (symptomatic benign prostatic hyperplasia). Br J Urol 80:587–596

5. Abrams PH (1977) A double-blind trial of the effects of candicidin on patients with benign prostatic hypertrophy. Br J Urol 49:67–71

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic work-up of benign prostatic hyperplasia;Die Urologie;2023-07-04

2. Benigne Prostatahyperplasie;Therapeutische Umschau;2023-04

3. Guidelines;Benign Prostate Syndrome;2023

4. Medikamentöse Behandlung des benignen Prostatasyndroms: Was gibt’s Neues?;Aktuelle Urologie;2022-02-22

5. Leitlinien;Benignes Prostatasyndrom;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3